Cardiovascular Risks and Outcome in COVID-19 Positive Patients With Cardiovascular Disease Attending Primary Health

Maktoum Abdul Azeez1, Abdul Hakeem Hamza1, Mohamed Ali Kalathingal1

  • 1Al Waab Health Center, Primary Health Care Corporation, Doha, Qatar.

Insights

Patients with cardiovascular disease (CVD) hospitalized with COVID-19 face increased risks. Age over 70 significantly elevates the risk of hospital admission for these patients.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Patients with pre-existing cardiovascular disease (CVD) exhibit elevated risks of morbidity and mortality when diagnosed with COVID-19.
  • This study investigates the specific risks and outcomes for COVID-19 patients with CVD within Qatar's primary healthcare settings.

Purpose of the Study:

  • To determine if cardiovascular disease (CVD) exacerbates the risk of hospitalization and subsequent complications in patients diagnosed with COVID-19.

Main Methods:

  • A retrospective cohort study was conducted.
  • Data from 10,178 COVID-19 positive patients with CVD were analyzed from electronic medical records between February 1, 2020, and December 31, 2020.
  • Multivariate analysis identified factors associated with inpatient admissions.

Main Results:

  • The study included 10,178 COVID-19 patients with CVD, with a median age of 50.83 years; 64% were male.
  • The most prevalent comorbidities were diabetes (69.6%), hypertension (68.4%), and dyslipidemia (45.1%).
  • Patients over 70 years old had a 2.8 times higher risk of hospital admission compared to those aged 25-30 years.

Conclusions:

  • Pre-existing cardiovascular disease (CVD), in conjunction with advanced age and other comorbidities, significantly predicts the risk of hospitalization and complications in COVID-19 patients.
  • Further research is recommended to explore long-term cardiovascular outcomes in COVID-19 survivors, utilizing data from both primary and secondary care.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...